Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 2,782,833 | 2,767,394 | 2,531,635 | 2,587,768 | 2,426,597 |
| Cost of Goods | 681,868 | 684,663 | 634,448 | 675,455 | 597,269 |
| Gross Profit | 2,100,965 | 2,082,731 | 1,897,187 | 1,912,313 | 1,829,328 |
| Operating Expenses | 953,972 | 929,556 | 872,376 | 805,960 | 785,683 |
| Operating Income | 1,147,861 | 1,153,838 | 1,025,259 | 1,106,808 | 1,043,914 |
| Interest Expense | 73,949 | 78,008 | 81,787 | 85,990 | 89,322 |
| Other Income | 5,777 | -231 | -3,324 | 1,665 | -3,505 |
| Pre-tax Income | 1,079,689 | 1,075,599 | 940,148 | 1,022,483 | 951,087 |
| Income Tax | 294,473 | 307,981 | 222,438 | 263,123 | 280,052 |
| Net Income Continuous | 785,216 | 767,618 | 717,710 | 759,360 | 671,035 |
| Minority Interests | -3,390 | -4,987 | -4,476 | -3,615 | -4,470 |
| Net Income | $788,606 | $772,605 | $722,186 | $762,975 | $675,505 |
| EPS Basic Total Ops | 0.51 | 0.51 | 0.47 | 0.50 | 0.45 |
| EPS Basic Continuous Ops | 0.51 | 0.50 | 0.47 | 0.50 | 0.44 |
| EPS Diluted Total Ops | 0.47 | 0.46 | 0.43 | 0.47 | 0.43 |
| EPS Diluted Continuous Ops | 0.46 | 0.45 | 0.43 | 0.47 | 0.42 |
| EBITDA(a) | $1,217,103 | $1,227,015 | $1,099,585 | $1,180,233 | $1,114,910 |